Patentability of natural products from Venomous Organisms: A guide for life science researchers.

Fuente: PubMed
Saved in:
Bibliographic Details
Main Authors: Ikonomopoulou, Maria P, Anderluh, Gregor, Coskun, Sahin, Merello Luna, Fernando, Modica, Maria Vittoria, Procházka, Jan, Rivera-de-Torre, Esperanza, Tarallo, Andrea, Violette, Aude
Format: Artículo científico
Language:en
Published: Toxicon : official journal of the International Society on Toxinology 2026
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266122528161794
author Ikonomopoulou, Maria P
Anderluh, Gregor
Coskun, Sahin
Merello Luna, Fernando
Modica, Maria Vittoria
Procházka, Jan
Rivera-de-Torre, Esperanza
Tarallo, Andrea
Violette, Aude
author_facet Ikonomopoulou, Maria P
Anderluh, Gregor
Coskun, Sahin
Merello Luna, Fernando
Modica, Maria Vittoria
Procházka, Jan
Rivera-de-Torre, Esperanza
Tarallo, Andrea
Violette, Aude
Ikonomopoulou, Maria P
Anderluh, Gregor
Coskun, Sahin
Merello Luna, Fernando
Modica, Maria Vittoria
Procházka, Jan
Rivera-de-Torre, Esperanza
Tarallo, Andrea
Violette, Aude
collection PubMed - marine biology
contents Patentability of natural products from Venomous Organisms: A guide for life science researchers. Ikonomopoulou, Maria P Anderluh, Gregor Coskun, Sahin Merello Luna, Fernando Modica, Maria Vittoria Procházka, Jan Rivera-de-Torre, Esperanza Tarallo, Andrea Violette, Aude Biological Products Venoms Animals Biological Science Disciplines Patents as Topic Intellectual Property This report is built on insights gathered during the European Venom Network (EUVEN) workshop on the patentability of natural compounds, with a particular focus on venom-derived molecules, held online on June 10, 2022. The program explored key aspects of Intellectual Property (IP) rights relevant to the development of therapeutic agents derived from natural sources, including animal venoms and toxins. Topics included IP considerations in biotechnology, strategies for building and managing IP portfolios, and licensing pathways from academic research to industry. The review further discusses the specific challenges and opportunities in patenting venom-based compounds, and outlines recommended practices for IP sharing within collaborative research consortia such as EUVEN. Finally, it incorporates perspectives from industry on fostering academic partnerships to advance the translational potential of venom-derived therapeutics. This document aims to serve as a practical guide for researchers at all career stages working in life sciences, particularly those engaged in the discovery and development of natural product-based innovations.
format Artículo científico
id pubmed_41297772
institution PubMed
language en
publishDate 2026
publisher Toxicon : official journal of the International Society on Toxinology
record_format pubmed
spellingShingle Patentability of natural products from Venomous Organisms: A guide for life science researchers.
Ikonomopoulou, Maria P
Anderluh, Gregor
Coskun, Sahin
Merello Luna, Fernando
Modica, Maria Vittoria
Procházka, Jan
Rivera-de-Torre, Esperanza
Tarallo, Andrea
Violette, Aude
Biological Products
Venoms
Animals
Biological Science Disciplines
Patents as Topic
Intellectual Property
Patentability of natural products from Venomous Organisms: A guide for life science researchers. Ikonomopoulou, Maria P Anderluh, Gregor Coskun, Sahin Merello Luna, Fernando Modica, Maria Vittoria Procházka, Jan Rivera-de-Torre, Esperanza Tarallo, Andrea Violette, Aude Biological Products Venoms Animals Biological Science Disciplines Patents as Topic Intellectual Property This report is built on insights gathered during the European Venom Network (EUVEN) workshop on the patentability of natural compounds, with a particular focus on venom-derived molecules, held online on June 10, 2022. The program explored key aspects of Intellectual Property (IP) rights relevant to the development of therapeutic agents derived from natural sources, including animal venoms and toxins. Topics included IP considerations in biotechnology, strategies for building and managing IP portfolios, and licensing pathways from academic research to industry. The review further discusses the specific challenges and opportunities in patenting venom-based compounds, and outlines recommended practices for IP sharing within collaborative research consortia such as EUVEN. Finally, it incorporates perspectives from industry on fostering academic partnerships to advance the translational potential of venom-derived therapeutics. This document aims to serve as a practical guide for researchers at all career stages working in life sciences, particularly those engaged in the discovery and development of natural product-based innovations.
title Patentability of natural products from Venomous Organisms: A guide for life science researchers.
topic Biological Products
Venoms
Animals
Biological Science Disciplines
Patents as Topic
Intellectual Property
url https://pubmed.ncbi.nlm.nih.gov/41297772/